Benedikt Hofauer1, Pierre Philip2, Markus Wirth3, Andreas Knopf3, Clemens Heiser3. 1. Otorhinolaryngology / Head and Neck Surgery, Klinikum rechts der Isar, Technical University Munich, Ismaningerstr. 22, 81675, Munich, Germany. b.hofauer@tum.de. 2. Clinique du Sommeil, CHU Bordeaux-Pellegrin, Bordeaux, France. 3. Otorhinolaryngology / Head and Neck Surgery, Klinikum rechts der Isar, Technical University Munich, Ismaningerstr. 22, 81675, Munich, Germany.
Abstract
PURPOSE: Selective upper-airway stimulation (UAS) is a novel therapy for patients with obstructive sleep apnea (OSA). The aim of this study was to compare changes in sleep architecture during the diagnostic polysomnography and the post-implantation polysomnography in UAS in patients with OSA. METHODS: Twenty-six patients who received a UAS device (Inspire Medical Systems) were included. Treatment outcome was evaluated 2 and 3 months after surgery. Data collection included demographics, body mass index (BMI), apnea hypopnea index (AHI), oxygen saturation and desaturation index (ODI), Epworth sleepiness score (ESS), arousal parameter, and sleep patterns. RESULTS: The mean age was 60.2 years, 25 patients were male, 1 patient was female. Mean BMI was 29.0 kg/m2. The mean pre-implantation AHI of 33.9/h could be reduced to 9.1/h at 2 months post-implantation (p < 0.001). The amount of time spent in N1-sleep could be reduced from 23.2% at baseline to 16.0% at month 3 post-implantation. The amount of time spent in N2- and N3-sleep did not change during the observation period. A significant increase of the amount of REM sleep at month 2 (15.7%) compared to baseline (9.5%; p = 0.010) could be observed. A reduction of the number of arousals and the arousal index could be observed. CONCLUSION: In conclusion, significant changes in sleep architecture of patients with OSA and sufficient treatment with UAS could be observed. A reduction of the amount of time spent in N1-sleep could be caused by treatment with UAS and the rebound of REM sleep, observed for the first time in a study on UAS, is also a potential marker of the efficacy of UAS on sleep architecture. TRIAL REGISTRATION: NCT02293746.
PURPOSE: Selective upper-airway stimulation (UAS) is a novel therapy for patients with obstructive sleep apnea (OSA). The aim of this study was to compare changes in sleep architecture during the diagnostic polysomnography and the post-implantation polysomnography in UAS in patients with OSA. METHODS: Twenty-six patients who received a UAS device (Inspire Medical Systems) were included. Treatment outcome was evaluated 2 and 3 months after surgery. Data collection included demographics, body mass index (BMI), apnea hypopnea index (AHI), oxygen saturation and desaturation index (ODI), Epworth sleepiness score (ESS), arousal parameter, and sleep patterns. RESULTS: The mean age was 60.2 years, 25 patients were male, 1 patient was female. Mean BMI was 29.0 kg/m2. The mean pre-implantation AHI of 33.9/h could be reduced to 9.1/h at 2 months post-implantation (p < 0.001). The amount of time spent in N1-sleep could be reduced from 23.2% at baseline to 16.0% at month 3 post-implantation. The amount of time spent in N2- and N3-sleep did not change during the observation period. A significant increase of the amount of REM sleep at month 2 (15.7%) compared to baseline (9.5%; p = 0.010) could be observed. A reduction of the number of arousals and the arousal index could be observed. CONCLUSION: In conclusion, significant changes in sleep architecture of patients with OSA and sufficient treatment with UAS could be observed. A reduction of the amount of time spent in N1-sleep could be caused by treatment with UAS and the rebound of REM sleep, observed for the first time in a study on UAS, is also a potential marker of the efficacy of UAS on sleep architecture. TRIAL REGISTRATION: NCT02293746.
Authors: Amy M Sawyer; Nalaka S Gooneratne; Carole L Marcus; Dafna Ofer; Kathy C Richards; Terri E Weaver Journal: Sleep Med Rev Date: 2011-06-08 Impact factor: 11.609
Authors: Babak Mokhlesi; Laurel A Finn; Erika W Hagen; Terry Young; Khin Mae Hla; Eve Van Cauter; Paul E Peppard Journal: Am J Respir Crit Care Med Date: 2014-11-15 Impact factor: 21.405
Authors: B Tucker Woodson; Ryan J Soose; M Boyd Gillespie; Kingman P Strohl; Joachim T Maurer; Nico de Vries; David L Steward; Jonathan Z Baskin; M Safwan Badr; Ho-sheng Lin; Tapan A Padhya; Sam Mickelson; W McDowell Anderson; Olivier M Vanderveken; Patrick J Strollo Journal: Otolaryngol Head Neck Surg Date: 2015-11-17 Impact factor: 3.497
Authors: Patrick Lévy; Malcolm Kohler; Walter T McNicholas; Ferran Barbé; R Doug McEvoy; Virend K Somers; Lena Lavie; Jean-Louis Pépin Journal: Nat Rev Dis Primers Date: 2015-06-25 Impact factor: 52.329
Authors: Patricia Sagaspe; Jacques Taillard; Guillaume Chaumet; Nicholas Moore; Bernard Bioulac; Pierre Philip Journal: Sleep Date: 2007-12 Impact factor: 5.849
Authors: Katrin Hasselbacher; B Hofauer; J T Maurer; C Heiser; A Steffen; J U Sommer Journal: Eur Arch Otorhinolaryngol Date: 2018-05-28 Impact factor: 2.503
Authors: Markus Wirth; Daniel Unterhuber; Franziska von Meyer; Benedikt Hofauer; Armin Ott; Guenther Edenharter; Danny J Eckert; Clemens Heiser Journal: J Clin Sleep Med Date: 2020-01-13 Impact factor: 4.062
Authors: Faith S Luyster; Quan Ni; Kent Lee; Christine Harrison; Vaibhav H Ramprasad; Ryan J Soose; Patrick J Strollo Journal: J Clin Sleep Med Date: 2022-09-01 Impact factor: 4.324
Authors: Marie Altendahl; Devyn L Cotter; Adam M Staffaroni; Amy Wolf; Paige Mumford; Yann Cobigo; Kaitlin Casaletto; Fanny Elahi; Leslie Ruoff; Samirah Javed; Brianne M Bettcher; Emily Fox; Michelle You; Rowan Saloner; Thomas C Neylan; Joel H Kramer; Christine M Walsh Journal: PLoS One Date: 2020-07-09 Impact factor: 3.240